These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Focus issue: signaling across membranes. Gough NR Sci STKE; 2005 Dec; 2005(313):eg11. PubMed ID: 16333016 [TBL] [Abstract][Full Text] [Related]
64. Focus issue: drug discovery. Gough NR Sci STKE; 2005 Aug; 2005(295):eg7. PubMed ID: 16077084 [TBL] [Abstract][Full Text] [Related]
65. Drug-target identification in Drosophila cells: combining high-throughout RNAi and small-molecule screens. Perrimon N; Friedman A; Mathey-Prevot B; Eggert US Drug Discov Today; 2007 Jan; 12(1-2):28-33. PubMed ID: 17198970 [TBL] [Abstract][Full Text] [Related]
66. How will RNAi facilitate drug development? Bartz S; Jackson AL Sci STKE; 2005 Aug; 2005(295):pe39. PubMed ID: 16077085 [TBL] [Abstract][Full Text] [Related]
67. Translational experimental therapeutics: The translation of laboratory-based discovery into disease-related therapy. Kieburtz K; Olanow CW Mt Sinai J Med; 2007 Apr; 74(1):7-14. PubMed ID: 17516559 [TBL] [Abstract][Full Text] [Related]
68. Proteomic methods for drug target discovery. Sleno L; Emili A Curr Opin Chem Biol; 2008 Feb; 12(1):46-54. PubMed ID: 18282485 [TBL] [Abstract][Full Text] [Related]
70. Importance of molecular computer modeling in anticancer drug development. Geromichalos GD J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268 [TBL] [Abstract][Full Text] [Related]
71. Genome-wide application of RNAi to the discovery of potential drug targets. Ito M; Kawano K; Miyagishi M; Taira K FEBS Lett; 2005 Oct; 579(26):5988-95. PubMed ID: 16153642 [TBL] [Abstract][Full Text] [Related]
72. Exploring the sounds of silence: RNAi-mediated gene silencing for target identification and validation. Chatterjee-Kishore M; Miller CP Drug Discov Today; 2005 Nov; 10(22):1559-65. PubMed ID: 16257379 [TBL] [Abstract][Full Text] [Related]